Insider Trading & Ownership - ABERNETHY MATT

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ABERNETHY MATT
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2025-02-13
Sale		2025-02-14
6:00 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,558$116.86$298,923101,739
(Direct)		View
2025-02-10
Sale		2025-02-12
6:41 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		980$118.27$115,90933,561
(Direct)		View
2025-01-31
Sale		2025-02-04
5:31 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,283$152.87$196,13635,118
(Direct)		View
2024-08-13
Sale		2024-08-15
5:12 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		14,100$150.38$2,120,34731,528
(Direct)		View
2024-07-16
Sale		2024-07-18
4:45 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		900$150.04$135,03745,628
(Direct)		View
2024-05-14
Sale		2024-05-16
4:40 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		30,000$137.95$4,138,43676,528
(Direct)		View
2024-02-13
Sale		2024-02-15
5:27 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,352$132.85$179,61285,552
(Direct)		View
2024-02-06
Sale		2024-02-08
7:12 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,260$138.73$313,53030,314
(Direct)		View
2024-01-31
Sale		2024-02-02
7:00 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,283$140.72$180,53928,284
(Direct)		View
2023-08-21
Sale		2023-08-23
7:58 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,132$107.39$228,95827,131
(Direct)		View
2023-02-06
Sale		2023-02-08
7:16 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		28,588$102.61$2,933,47025,213
(Direct)		View
2023-01-31
Sale		2023-02-02
4:53 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,283$109.98$141,10821,357
(Direct)		View
2022-02-07
Sale		2022-02-09
6:51 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		4,290$80.53$345,48620,204
(Direct)		View
2021-12-01
Sale		2021-12-03
5:02 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,645$82.59$135,85216,349
(Direct)		View
2021-02-08
Sale		2021-02-09
9:30 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,910$116.82$339,94266,940
(Direct)		View
2020-12-01
Sale		2020-12-02
4:12 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,645$94.66$155,72111,494
(Direct)		View
2020-11-12
Sale		2020-11-16
6:02 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,257$90.74$204,81010,014
(Direct)		View
2020-08-05
Sale		2020-08-07
6:22 pm		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,257$118.9$268,3567,983
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2025-05-29
Option Award		2025-05-30
4:06 pm		N/A
2035-05-28		FATE THERAPEUTICS INCFATEABERNETHY MATT
Director		110,000$0110,000
(Direct)		View
2025-02-12
Option Award		2025-02-14
6:00 pm		N/A
2035-02-12		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		54,072$0101,739
(Direct)		View
2025-02-13
Exercise		2025-02-14
6:00 pm		N/A
N/A		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		4,807$0101,739
(Direct)		View
2025-02-08
Exercise		2025-02-12
6:41 pm		N/A
N/A		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		1,860$033,561
(Direct)		View
2025-01-31
Exercise		2025-02-04
5:31 pm		N/A
N/A		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		2,436$035,118
(Direct)		View
2024-08-13
Exercise		2024-08-15
5:12 pm		N/A
2027-12-01		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		14,100$031,528
(Direct)		View
2024-08-13
Exercise		2024-08-15
5:12 pm		N/A
N/A		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		14,100$73.631,528
(Direct)		View
2024-07-16
Exercise		2024-07-18
4:45 pm		N/A
2027-12-01		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		900$045,628
(Direct)		View
2024-07-16
Exercise		2024-07-18
4:45 pm		N/A
N/A		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		900$73.645,628
(Direct)		View
2024-05-14
Exercise		2024-05-16
4:40 pm		N/A
2027-12-01		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		30,000$73.676,528
(Direct)		View
2024-02-13
Option Award		2024-02-15
5:27 pm		N/A
2034-02-13		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		54,024$085,552
(Direct)		View
2023-02-13
Option Award		2023-02-15
7:04 pm		N/A
2033-02-13		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		74,053$074,053
(Direct)		View
2022-01-31
Option Award		2022-02-02
7:54 pm		N/A
2032-01-31		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		76,107$076,107
(Direct)		View
2021-02-08
Option Award(A)		2021-03-26
9:48 pm		N/A
2031-02-08		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		49,049$049,049
(Direct)		View
2021-02-08
Option Award		2021-02-09
9:30 pm		N/A
2031-02-08		NEUROCRINE BIOSCIENCES INCNBIXABERNETHY MATT
Chief Financial Officer		52,071$066,940
(Direct)		View
(A) Indicate amendment filing.